Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction
Clinical trial NCT03274752 · COMPLETED
Trial details
- NCT number
- NCT03274752
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-26
- Primary completion
- 2021-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.